The Comparison of Simple Anthropometric and Biochemical Parameters for Predicting Liver Steatosis in Obese Balinese Young Women
DOI:
https://doi.org/10.3889/oamjms.2018.449Keywords:
non-alcoholic fatty liver disease, waist circumference, body mass index, non-alcoholic steatohepatitisAbstract
BACKGROUND: The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing globally. Early identification of liver steatosis (LS) status is critical to prevent the development of NAFLD into non-alcoholic steatohepatitis (NASH) fibrosis.
AIM: This study aimed at exploring the validity of simple anthropometric and biochemical parameters to predict LS in young obese women.
MATERIALS AND METHODS: This is a cross-sectional study involving 132 young obese women. We collected the data of measured waist circumference (WC), body mass index (BMI), serum triglyceride (TG), and gamma-glutamyltransferase (GGT). The lipid accumulation product (LAP) was designed from TG and WC variables. Fatty liver index (FLI) was calculated from TG, BMI, WC, and GGT variables. LS status was measured using ultrasonography assay. Statistical significance was set at p < 0.05.
RESULTS: A positive correlation was found between BMI, WC, TG, GGT, LAP, FLI, and LS (p = 0.001). We found that BMI is a better predictor for LS to WC. Our multiple linear regression analysis revealed that BMI, GGT,and TG could predict 41.4% of LS. The validity (specificity, sensitivity, and odds ratio) of simple body fat parameters in predicting LS were as follows: BMI ≥ 30 kg/m2 (69.6%, 74.4%, and 6.21), WC ≥ 90 cm (67.4%, 70.0%, and 4.28), TG ≥ 100 mg/dL (70.6%, 70.0%, and 5.62) and GGT ≥ 20 μg/L (69.6%, 77.5%, and 7.87), as well as LAP ≥ 30 (82.6%, 70.0%, and 11.1), and FLI ≥ 2.5 (79.3%, 72.5%, and 10.1), significantly.
CONCLUSION: Simple anthropometric and biochemical parameters (BMI, WC, and TG, GGT), are appropriately predicting LS as well as LAP, and FLI among obese Balinese young women.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Schwenger KJ, Allard JP. Clinical approaches to non-alcoholic fatty liver disease. World Journal of Gastroenterology. 2014; 20(7):1712-1723. https://doi.org/10.3748/wjg.v20.i7.1712 PMid:24587650 PMCid:PMC3930971
More JB. Non-alcoholic fatty liver disease: the hepatic consequence of obesity and metabolic syndrome. Proc Nutr Soc. 2010; 69(2):211-20. https://doi.org/10.1017/S0029665110000030 PMid:20158939
Wong VW-S. Nonalcoholic fatty liver disease in Asia: A story of growth. Journal of Gastroenterology and Hepatology. 2012; 28(1):18-23. https://doi.org/10.1111/jgh.12011 PMid:23094755
Marengo A, Jouness RIK, Bugianesi E. Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults. Clinics in Liver Disease. 2016; 20(2):313-324. https://doi.org/10.1016/j.cld.2015.10.010 PMid:27063271
Roriz AKC, Passos LCS, de Oliveira CC, Eickemberg M, Moreira P de A, Sampaio LR. Evaluation of the Accuracy of Anthropometric Clinical Indicators of Visceral Fat in Adults and Elderly. PLoS ONE. 2014; 9(7):e103499. https://doi.org/10.1371/journal.pone.0103499 PMid:25078454 PMCid:PMC4117503
Bedogni G, Bellentani S, Miglioli L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterology. 2006; 6(1). https://doi.org/10.1186/1471-230X-6-33 PMid:17081293 PMCid:PMC1636651
Castera L, Vilgrain V, Angulo P. Noninvasive Evaluation of NAFLD. Nature Reviews Gastroenterology & Hepatology. 2013; 10(11): 666–75. https://doi.org/10.1038/nrgastro.2013.175 PMid:24061203
Lee SS, Park SH. Radiologic evaluation of nonalcoholic fatty liver disease. World Journal of Gastroenterology. 2014; 20(23):7392-7402. https://doi.org/10.3748/wjg.v20.i23.7392 PMid:24966609 PMCid:PMC4064084
Bedogni G, Kahn HS, Bellentani S, Tiribelli C. A simple index of lipid overaccumulation is a good marker of liver steatosis. BMC Gastroenterology. 2010; 10(98). https://doi.org/10.1186/1471-230X-10-98
Chiang J-K, Koo M. Lipid accumulation product: a simple and accurate index for predicting metabolic syndrome in Taiwanese people aged 50 and over. BMC Cardiovascular Disorders. 2012; 12(1). https://doi.org/10.1186/1471-2261-12-78 PMid:23006530 PMCid:PMC3506496
Kahn HS. The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovascular Disorders. 2005; 5:26. https://doi.org/10.1186/1471-2261-5-26 PMid:16150143 PMCid:PMC1236917
Hamaguchi M, Kojima T, Itoh Y, et al. The Severity of Ultrasonographic Findings in Nonalcoholic Fatty Liver Disease Reflects the Metabolic Syndrome and Visceral Fat Accumulation. The American Journal of Gastroenterology. 2007; 102(12):2708-2715. https://doi.org/10.1111/j.1572-0241.2007.01526.x PMid:17894848
Festi D, Schiumerini R, Marzi L, et al. Review article: the diagnosis of non-alcoholic fatty liver disease - availability and accuracy of noninvasive methods. Aliment Pharmacol Ther. 2013; 37(4):392-400. https://doi.org/10.1111/apt.12186 PMid:23278163
Wree A, Broderick L, Canbay A, Hoffman HM, Feldstein AE.From NAFLD to NASH to Cirrhosis - new insights into disease mechanisms. Nat RevGastroenterolHepatol. 2013; 10(11):627-636. https://doi.org/10.1038/nrgastro.2013.149
Weta IW, Mahadewa TGB, Sutirtayasa WP, Subawa AAN, Malik SG, Widyadharma IPE. Supplementation With 2:1 Ratio Of N-6:n-3 Polyunsaturated Fatty Acid Improves Liver Steatosis And Serum Cytokine Levels In Young Obese Balinese Women: A Randomized Clinical Trial. Asian Journal of Pharmaceutical and Clinical Research. 2017; 10(12):74. https://doi.org/10.22159/ajpcr.2017.v10i12.20851
Weta IW, Sutirtayasa WP, Subawa AAN, Malik SG. Supplementation 2000mg and 1000mg of linoleic acid and alfa linolenic acid delayed pre diabetic state in Balinese young obese women: A Randomised Clinical Trial. Bali Medical Journal. 2017; 6(3):55. https://doi.org/10.15562/bmj.v6i3.721
Oshakbayev K, Nersesov A, Izatullayev E, Kaybullayeva J, Nugmanova M, Ilyassova B. Correlation between body fat mass and nonalcoholic fatty liver disease. Medical and Health Science Journal. 2011; 6:60-67. https://doi.org/10.15208/mhsj.2010.109
Cuthbertson DJ, Weickert MO, Lythgoe D, et al. External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals. European Journal of Endocrinology. 2014; 171(5):561-569. https://doi.org/10.1530/EJE-14-0112 PMid:25298375
Zelber-Sagi S, Webb M, Assy N, et al. Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification. World Journal of Gastroenterology. 2013; 19(1):57-64. https://doi.org/10.3748/wjg.v19.i1.57 PMid:23326163 PMCid:PMC3542754
Du T, Yu X, Zhang J, Sun X. Lipid accumulation product and visceral adiposity index are effective markers for identifying the metabolically obese normal-weight phenotype. Acta Diabetologica. 2015; 52(5):855-863. https://doi.org/10.1007/s00592-015-0715-2 PMid:25690647
Motamed N, Sohrabi M, Ajdarkosh H, et al. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease. World Journal of Gastroenterology. 2016; 22(10):3023-3030. https://doi.org/10.3748/wjg.v22.i10.3023 PMid:26973398 PMCid:PMC4779925
Rinella ME, Alonso E, Rao S, et al. Body mass index as a predictor of hepatic steatosis in living liver donors. Liver Transpl. 2001; 7(5): 409-414. https://doi.org/10.1053/jlts.2001.23787 PMid:11349260
Stranges S, Dorn JM, Muti P, et al. Body fat distribution, relative weight, and liver enzyme levels: apopulation-based study. Hepatology. 2004; 39(3):754-763. https://doi.org/10.1002/hep.20149 PMid:14999694
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2018 I Wayan Weta, Tjokorda Gde Bagus Mahadewa, Wayan Putu Sutirtayasa, AAN Subawa, Firman P. Sitanggang, I Putu Eka Widhyadarma
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0